Covering a key topic due to growing research into the role of signaling mechanisms in toxicology, this book focuses on practical approaches for informatics, big data, and complex data sets.
* Combines fundamentals / basics with experimental applications that can help those involved in preclinical drug studies and translational research
* Includes detailed presentations of study methodology and data collection, analysis, and interpretation
* Discusses tools like experimental design, sample handling, analytical measurement techniques
Inhaltsverzeichnis
List of Contributors xv
About the Editors xvii
Preface xix
1 Introduction to Cellular Signal Transduction: The Connection Between a Biological System and Its Surroundings 1
Jonathan W. Boyd, Richard R. Neubig, Alice Han, and Maren Prediger
1. 1 Starting Big, but Ending Small 3
1. 1. 1 Key Features of Signal Transduction 3
1. 2 Responding to Our Environment: Sensory Perception Begins and Ends with Signal Transduction 4
1. 2. 1 Taste (Gustation) 4
1. 2. 2 Smell (Olfaction) 5
1. 2. 3 Sight (Vision) 6
1. 2. 4 Sound (Audition) 6
1. 2. 5 Touch (Somatosensation) 8
1. 3 Primary Transport Systems Involved in Signal Transduction 8
1. 3. 1 Ion Channels, Transporters, and Ion Pumps 9
1. 3. 2 Receptors 10
1. 3. 3 Endocytosis 10
1. 3. 4 Exosomes 11
1. 4 Key Organelles Involved in Signal Transduction 12
1. 4. 1 Mitochondria 12
1. 4. 2 Endoplasmic Reticulum 14
1. 4. 3 Nucleus 15
References 16
2 Mechanisms of Cellular Signal Transduction 21
Richard R. Neubig, Jonathan W. Boyd, Julia A. Mouch, and Nicole Prince
2. 1 Posttranslational Modifications and Their Roles in Signal Transduction 22
2. 1. 1 Phosphorylation 22
2. 1. 2 Acylation 24
2. 1. 3 Alkylation 25
2. 1. 4 Glycosylation 26
2. 1. 5 Other PTMs 27
2. 2 Receptors 27
2. 3 Receptor Signaling Mechanisms 29
2. 3. 1 Basic Principles of Signal Transduction Mechanisms 29
2. 3. 1. 1 Selectivity and Recognition 31
2. 3. 1. 2 Flexible Modularity 31
2. 3. 1. 3 Molecular Switches 34
2. 3. 1. 4 GPCRs and Second Messengers 36
2. 3. 1. 5 Amplification 39
2. 3. 1. 6 Turn Off Mechanisms 40
2. 3. 1. 7 Localization 40
2. 3. 1. 8 Biased Signaling/Functional Selectivity 41
2. 4 Receptor Tyrosine Kinases 42
2. 5 Steroid Receptors 43
2. 6 Reactive Oxygen Species (ROS) 43
2. 7 Summary 44
References 44
3 From Cellular Mechanisms to Physiological Responses: Functional Signal Integration Across Multiple Biological Levels 49
Robert H. Newman
3. 1 Introduction 49
3. 2 Cellular Information Flow: Mechanisms of Cellular Signal Integration and Regulation 50
3. 2. 1 The InsR aPKC NF B Signaling Axis 51
3. 2. 2 Modes of Regulation in InsR PKC NF B Signaling Axis 54
3. 2. 3 Transcriptional Regulation 54
3. 2. 4 Regulating the Regulators: Phosphatase Mediated Regulation of Signaling Molecules 59
3. 3 Crosstalk and Functional Signal Integration in Response to Insulin in Hepatocytes 60
3. 4 Systemic Signal Integration 65
3. 4. 1 Pancreatic ß Cells 65
3. 4. 2 Skeletal Muscles 66
3. 4. 3 Adipose Tissue 67
3. 5 Dysregulation of Insulin Signaling in the Etiology of Type 2
Diabetes 67
References 69
4 Signal Transduction in Disease: Relating Cell Signaling to Morbidity and Mortality 73
Patricia E. Ganey and Sean A. Misek
4. 1 Introduction 73
4. 2 Fibrosis as an Example of Complex Signaling 75
4. 2. 1 Development of Liver Fibrosis 75
4. 2. 2 Animal Models of Hepatic Fibrosis 76
4. 2. 3 Activation of Hepatic Stellate Cells 77
4. 2. 4 Epithelial tö Mesenchymal Transition (EMT) 78
4. 2. 5 Other Cellular Interactions in Fibrosis 78
4. 2. 6 Intracellular Signaling Pathways Critical to Liver Fibrosis 80
4. 2. 6. 1 TGF ß 1 80
4. 2. 6. 2 Kinase Pathways Involved in Fibrotic Responses 82
4. 2. 6. 3 HIF 1 83
4. 2. 6. 4 miRNA 84
4. 2. 6. 5 Toll Like Receptors (TLRs) 84
4. 3 Cancer Drug Resistance: Complex Cellular and Population Changes 85
4. 3. 1 Genomic Resistance Mechanisms 85
4. 3. 2 Non genomic Mechanisms 88
4. 3. 3 Non cancer Drug Resistance Paradigms 88
4. 3. 4 Tumor Heterogeneity as a Driver of Drug Resistance 89
4. 3. 5 Mutational Drivers of Drug Resistance 90
4. 3. 6 Drug Induced Rewiring of Signaling Networks as a Mechanism of Drug Resistance 91
4. 3. 7 Parallel Pathways and Combination Treatments 93
4. 3. 8 Epigenetic Mechanisms of Drug Resistance 95
4. 3. 9 Summary of Cancer Drug Resistance 97
4. 4 Summary 98
References 98
5 Experimental Design in Signal Transduction 113
Weimin Gao, Meghan Cromie, Qian Wang, Zhongwei Liu, Song Tang, and Julie Vrana Miller
5. 1 Overview of Basic Experimental Design 113
5. 1. 1 Independent Sample t Test 114
5. 1. 2 Completely Randomized Analysis of Variance (ANOVA) 114
5. 1. 3 t Test for Dependent Sample Design 115
5. 1. 4 Randomized Block Design 115
5. 1. 5 Completely Randomized Factorial Design 116
5. 1. 6 Summary 116
5. 2 Aseptic Technique 116
5. 2. 1 Sterile Work Environment and Laminar Flow Hood 117
5. 2. 2 Good Personal Hygiene Practices 117
5. 2. 3 Sterile Reagents and Materials 118
5. 2. 4 Sterile Handling 118
5. 3 Biological Sample Collection, Processing, and Pretreatment Technology 119
5. 3. 1 Sample Collection 119
5. 3. 1. 1 Sample Collection In Vivo 119
5. 3. 1. 2 Cell Culture In Vitro 120
5. 3. 2 Sample Processing 121
5. 3. 2. 1 DNA Isolation 121
5. 3. 2. 2 RNA Extraction 121
5. 3. 2. 3 Protein Extraction 122
5. 4 Sample Storage 122
5. 5 Common In Vitro Studies in Toxicology/Pharmacology 123
5. 5. 1 Cytotoxicity Studies 123
5. 5. 2 Viability Assays 123
5. 5. 2. 1 Trypan Blue 123
5. 5. 2. 2 Erythrosin 124
5. 5. 2. 3 Crystal Violet Staining 124
5. 5. 2. 4 Neutral Red Staining 125
5. 5. 3 Survival Assays 125
5. 5. 3. 1 Clonogenic or Colony Formation Assay 125
5. 5. 3. 2 Cell Cycle Analysis: Flow Cytometry 126
5. 5. 4 DNA Damage Assays 126
5. 5. 4. 1 Comet Assay 127
5. 5. 4. 2 Sister Chromatid Exchange Assay 127
5. 5. 5 Southern Blot and DNA Sequencing 127
5. 5. 5. 1 Southern Blot 127
5. 5. 5. 2 DNA Sequencing 128
5. 5. 5. 3 Transfection and Gene Silencing 128
5. 5. 6 RNA Quantification and Identification 128
5. 5. 6. 1 Northern Blot 128
5. 5. 6. 2 Promoter Deletion Analysis 129
5. 5. 6. 3 RNase Protection Assay 129
5. 5. 7 Gene Expression 129
5. 5. 7. 1 Quantitative Real Time Polymerase Chain Reaction (qRT PCR) 130
5. 5. 7. 2 Microarray 130
5. 5. 8 Protein Related Assays 131
5. 5. 8. 1 Bradford Assay 131
5. 5. 8. 2 Enzyme-Linked Immunosorbent Assay (ELISA) 131
5. 5. 8. 3 Western Blot and 2D Gel Electrophoresis 131
5. 5. 8. 4 Immunolocalization 132
5. 5. 8. 5 Immunoprecipitation Assays 132
5. 5. 8. 6 Chromatin Immunoprecipitation (ChIP) 132
5. 5. 9 Epigenetics 133
5. 5. 9. 1 Bisulfite Pyrosequencing 133
5. 5. 9. 2 ChIP on Chip 133
5. 5. 9. 3 Multiplex miRNA Profiling 134
5. 6 Common In Vivo Studies in Toxicology 134
5. 6. 1 Toxicological Endpoints 134
5. 6. 1. 1 Maximum Tolerated Dose (MTD) 134
5. 6. 1. 2 Acute, Subchronic, and Chronic Toxicity 135
5. 6. 1. 3 Reproductive and Developmental Toxicity 135
5. 6. 1. 4 Genotoxicity and Carcinogenicity Studies 136
5. 6. 2 Routes of Exposure 136
5. 6. 2. 1 Oral, Dermal, and Inhalation 136
5. 6. 2. 2 Exposure via Injection 137
5. 6. 3 Animal Models 137
5. 6. 3. 1 Rodent Studies 137
5. 6. 3. 2 Other Studies 138
5. 7 Basic Advantages and Disadvantages Associated with Sample Types 138
5. 8 Human Epidemiology Studies 138
5. 8. 1 Nonexperimental Studies 139
5. 8. 2 Experimental Studies 139
5. 8. 3 Molecular Epidemiology 140
5. 9 Examples of Tox and Pharm Based Experiments Relevant to Signal Transduction Endpoints 140
5. 9. 1 Cytotoxicity 141
5. 9. 1. 1 Nicotine Derived Nitrosamine Ketone (NNK) 141
5. 9. 1. 2 Doxorubicin (DOX) 142
5. 9. 1. 3 Curcumin 142
5. 9. 1. 4 Combination Effects of Cisplatin and/or Leptomycin B (LMB) 143
5. 9. 2 DNA Damage 143
5. 9. 3 Cell Cycle and Apoptosis 145
5. 9. 4 ROS Induction in A549 Cells After LMB and Epigallocatechin Gallate (EGCG) Treatment 146
5. 9. 5 Signaling Pathways 146
5. 9. 5. 1 Metabolizing Alterations After Chemical Exposure 146
5. 9. 5. 2 p53 Signaling Pathways 148
5. 9. 6 Protein Kinase B (Akt/PKB)/Mechanistic Target of Rapamycin (mTOR) Pathway Analysis Using Multiblot 150
5. 9. 7 Discovery of Unrecognized Pathways/Molecules Using Proteomics 150
5. 10 Coupling Experimental Results Within the Larger Literature Framework to Generate Information 152
5. 10. 1 Cell Proliferation-EGFR Pathway 152
5. 10. 2 Cell Cycle 154
5. 10. 3 Signal Mediated Cell Death 156
5. 10. 4 Reactive Oxygen Species (ROS) 161
References 162
6 Techniques for Measuring Cellular Signal Transduction 171
Julie Vrana Miller, Weimin Gao, Meghan Cromie, and Zhongwei Liu
6. 1 Introduction 171
6. 2 High Throughput Versus High Content Data 172
6. 2. 1 Ergodic and Nonergodic Systems 173
6. 3 Methods to Measure Signal Transduction Data 173
6. 3. 1 Microscopy 173
6. 3. 1. 1 Widefield Epifluorescence Microscopy 173
6. 3. 1. 2 Confocal Microscopy 174
6. 3. 1. 3 Immunohistochemistry 175
6. 3. 1. 4 FRET 178
6. 3. 2 Enzyme Linked Immunosorbent Assay (ELISA) 179
6. 3. 2. 1 Competitive ELISA 179
6. 3. 2. 2 Sandwich ELISA 180
6. 3. 2. 3 Direct Cellular ELISA 180
6. 3. 2. 4 Multiplex Suspension Array Assays 181
6. 3. 2. 5 Electrochemiluminescence (ECL) Array 182
6. 3. 3 Gel Electrophoresis 183
6. 3. 4 Western Blot 183
6. 3. 5 Protein Nuclear Magnetic Resonance (NMR) 186
6. 4 Techniques to Generate Large Datasets for Signal Transduction Network Analysis 187
6. 4. 1 ' omics Using Mass Spectrometry 187
6. 4. 1. 1 Separation Techniques 188
6. 4. 1. 2 Phosphoprotein Enrichment for Phosphoproteomics: IMAC, MOAC, and SMOAC 189
6. 4. 1. 3 Quantitation with Chemical Tags: iTRAQ and TMT 190
6. 4. 2 RNA Sequencing (RNA Seq) 190
6. 5 Bioenergetics 191
6. 5. 1 Oxygen Consumption 191
6. 5. 2 Reactive Oxygen Species (ROS) Fluorescent Probes 192
6. 5. 3 ATP Assays 193
6. 5. 4 Nicotinamide Adenine Dinucleotide (NADH) Assay 193
6. 5. 5 Mitochondrial Membrane Potential 194
6. 6 Relating Signaling to Cellular Outcome Using Relevant Assays 194
6. 6. 1 MTT/MTS/WST Assays 194
6. 6. 2 LDH Assay 195
6. 6. 3 Resazurin Assay (Alamar Blue) 196
6. 6. 4 Cell Death: Plasma Membrane Degradation Assay 196
6. 7 Summary 196
References 197
7 Computational Methods for Signal Transduction: A Network Approach 201
Giovanni Scardoni, Gabriele Tosadori, John Morris, Sakshi Pratap, Carlo Laudanna, and Alice Han
7. 1 Introduction 201
7. 2 Network Construction 203
7. 2. 1 Introduction to Network Construction 203
7. 2. 2 Network Construction from a Probe 203
7. 2. 3 Mapping Methodology 204
7. 2. 4 Small Networks 208
7. 2. 5 Large Networks 208
7. 3 Facing the Network Analysis 209
7. 3. 1 Centralities Definition and Description 211
7. 3. 2 Global Parameters 211
7. 3. 2. 1 Diameter ( G) 211
7. 3. 2. 2 Average Distance 212
7. 3. 3 Local Parameters 213
7. 3. 3. 1 Degree 213
7. 3. 3. 2 Eccentricity 214
7. 3. 3. 3 Closeness 215
7. 3. 3. 4 Radiality 215
7. 3. 3. 5 Centroid Value 217
7. 3. 3. 6 Stress 219
7. 3. 3. 7 S. P. Betweenness 219
7. 3. 3. 8 Eigenvector 220
7. 3. 3. 9 Bridging Centrality 221
7. 3. 3. 10 Edge Betweenness 221
7. 3. 3. 11 Normalization and Relative Centralities 222
7. 3. 4 Clusters 222
7. 4 Employing Centrality Analysis to Evaluate Stressed Biological Systems 224
7. 5 Interference Notion: How to Perform Virtual Knockout Experiments on Biological Networks 226
7. 5. 1 Integrating Experimental Dataset into a Topological Analysis 227
7. 5. 2 Integrating Expression or Activation Levels as Nodes Attributes 228
7. 5. 3 Edge Attributes as Distance in a Computation 228
7. 6 Network Analysis Software 229
7. 6. 1 Cytoscape and Its Apps 229
7. 6. 1. 1 structureViz/RINalyzer 231
7. 6. 1. 2 CentiScaPe 231
7. 6. 1. 3 PesCa 231
7. 6. 1. 4 Interference 231
7. 6. 1. 5 clusterMaker2 232
7. 6. 1. 6 chemViz 233
7. 6. 2 Other Tools 233
7. 6. 2. 1 Gephi 233
7. 6. 2. 2 D3. js 234
7. 6. 2. 3 VisANT 234
7. 7 Conclusions 236
References 236
8 A Toxicological Application of Signal Transduction: Early Cellular Changes Can Be Indicative of Toxicity 239
Julie Vrana Miller, Nicole Prince, Julia A. Mouch, and Jonathan W. Boyd
8. 1 Introduction 239
8. 2 Classification of Toxic Agent and Exposure Effects: A Toxicological Perspective 240
8. 2. 1 Dose-Response for Chemical Exposure Toxicity Testing and Risk Assessment 240
8. 2. 2 Chemical Mixtures 241
8. 2. 3 Mode of Action Versus Mechanism of Action 242
8. 3 Early Cellular Changes Post exposure 244
8. 3. 1 Intracellular Signaling Perturbations Associated with Exposure 245
8. 3. 2 Bioenergetic Changes Post exposure 248
8. 3. 3 Time Scale of Exposure Effects 249
8. 4 Experimentally Testing Early Cellular Changes that May Contribute to Exposure Sensing and Response 250
8. 4. 1 Paradigm Shift Toward In Vitro Cell Culture 250
8. 4. 2 Real Time In Vitro Assays to Measure Early Cellular Changes 251
8. 4. 2. 1 Using NADH and Oxygen Consumption to Predict ATP Generation 252
8. 4. 3 Prediction of Posttranslational Phosphorylation Response for Mixtures 253
8. 4. 3. 1 Using Bliss Independence (Response Addition) to Predict Relative Phosphorylation During Critical Signaling Events 253
References 256
Appendix A 262
9 Future Research in Signaling 267
Jonathan W. Boyd, Nicole Prince, and Marc Birringer
9. 1 Translational Research and a Spatiotemporal Understanding of Signal Transduction 267
9. 2 Integrating Second Messengers into Signal Transduction 270
9. 3 Understanding Crosstalk in Signal Transduction 272
9. 4 Posttranslational Modifications (PTMs) and Target Identification in Signal Transduction 274
9. 5 Epigenetic Endpoints in Signal Transduction 276
9. 6 The Integration of Nutrition and Signal Transduction 278
9. 6. 1 Cellular AMPK Signaling 281
9. 6. 2 Cellular TOR Signaling 282
9. 6. 3 Gut Microbiota 282
9. 6. 4 The Integration of Endocrine Gut Signaling 283
References 284
Index 291